Because spontaneous resolution in cases of<unk>  is a rarity, the majority of patients require treatment. The recommended treatment regimens are largely empirical and predominantly based upon retrospective evaluations, case study reports, and nonrandomized control trials. The predominant therapy for<unk>  is itraconazole, which is used as the primary treatment in immunocompetent patients, and as a suppressive therapy in immunocompromised patients. The primary line of treatment for  immunocompromised patients is amphotericin B.
Sporotrichosis medical therapy
Mucormycosis medical therapy
Zygomycosis medical therapy
Actinomycosis medical therapy
Blastomycosis medical therapy
Aspergillosis medical therapy
Mycosis fungoides medical therapy
Paracoccidioidomycosis medical therapy